1.
Comparison of intravitreal ranibizumab and aflibercept in patients with choroidal neovascularization in pathologic myopia. Ukr. j. ophthalmol. [Internet]. 2026 Jun. 4 [cited 2026 Aug. 9];(5):34-8. Available from: https://ua.ozhurnal.com/index.php/files/article/view/852